Product Name: DLL1 Antibody [D1L165-6]
Species Reactivity: Human
Tested Applications: ELISA, WB
Applications: ELISA: (direct and indirect: 1:2,000-1:5,000). Western Blot: (1:2,000-1:5,000 using ECL. Suggested blocking and dilution buffer is PBST containing 0.05% Tween 20 and 5% skim milk. Suggested incubation time is 1 hour at room temperature). Optimal conditions must be determined individually for each application.
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight:
Immunogen: Recombinant human DLL1.
Host Species: Mouse
Purification:
Physical State: Liquid
CAS NO.: 540737-29-9
Product: Tofacitinib (citrate)
Buffer: Liquid. 0.2um-filtered solution in PBS, pH 7.4. Contains no preservatives.
Concentration: 1 mg/ml
Storage Conditions: Stable for at least 1 year after receipt when stored at -20˚C.
Clonality: Monoclonal
Conjugate: Unconjugated
Alternate Names: Delta-like Protein 1; Delta1
Accession NO.: NP_005609
Protein Ino: 110735443
Official Symbol: DLL1
Geneid: 28514
Background: The Notch ligand delta-like protein 1 (DLL1) is essential for postnatal arteriogenesis and contributes to tumor progression. DLL1 is involved in differentiation and self-renewal of adipocyte stem cells. Blocks the differentiation of progenitor cells into the B cell lineage while promoting the emergence of a population of cells with the characteristics of a T-cell/NK-cell precursor.
PubMed ID:http://aac.asm.org/content/38/9/2041.abstract
